The aim of this award is to support research training and research projects in the area of chromosome activities and their links to cancer. This includes (but is not limited to) research on mechanisms of DNA replication, repair, rearrangement and modification; transcription, splicing and RNA modification; chromatin structure and epigenetics; mitosis, chromosome segregation and instability; oncogenes and tumor suppressors; tumor initiation and progression; cell transformation, differentiation, apoptosis and senescence; cell-cell and cell-matrix interactions, adhesion, migration and growth factors; and other areas of chromosome and cancer biology. Candidates pursuing research in other areas are encouraged to apply: fellowships will be awarded based on qualifications as well as relevance.
The trainee must be a U.S. citizen, non-citizen national, or have permanent resident status. NIH training grant funding guidelines stipulate that no individual trainee may receive more than 5 years of aggregate Kirschstein-NRSA support at the predoctoral level and 3 years of aggregate Kirschstein-NRSA support at the postdoctoral level, including any combination of support from Kirschstein-NRSA institutional research training grants and individual fellowships. Therefore, trainees who have already received this level of NIH funding are not eligible to apply for the training grant fellowships. Support from NIH research project grants awarded to faculty do not count towards the 3 year eligibility rule.
Fred Hutch is an Equal Opportunity Employer. Underrepresented minorities and economically disadvantaged individuals are strongly encouraged to apply.
Currently accepting applications for a postdoctoral fellow. Due date: October 10th, by 5pm.
Stipend will be awarded for two years with a third year dependent on progress.